SiddharthSinghMD

Advanced Endoscopic Interventional, Inflammatory Bowel Disease

Physician

Dr. Singh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9500 Gilman Dr
# Mail
La Jolla, CA 92093
Phone+1 619-543-2347

Fax+1 858-657-7259

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2011 - 2014
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2008 - 2011
All India Institute of Medical SciencesClass of 2007

Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients Start of enrollment: 2020 Dec 18
Recruiting
Phase 2
Roles: Contact, Principal Investigator

PubMed

Placebo Rates in Crohn's Disease Randomized Clinical Trials: An Individual Patient Data Meta-Analysis.
Virginia Solitano, Malcolm Hogan, Siddharth Singh, Silvio Danese, Laurent Peyrin-Biroulet
Gastroenterology. 2025-02-01
1 citations
Long-Term Outcomes of an Infliximab-First Versus Vedolizumab-First Treatment Strategy in Biologic-Naïve Patients With Ulcerative Colitis.
Austin Haynesworth, Kuan-Hung Yeh, Han Hee Lee, Melissa Kirkpatrick, Brigid S Boland
Alimentary Pharmacology & Therapeutics. 2025-02-01
2 citations
Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis.
Mohammad Shehab, Fatema Alrashed, Abdulwahab Alsayegh, Usama Aldallal, Christopher Ma
Clinical Gastroenterology and Hepatology. 2025-02-01

Journal Articles

Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel Diseases
Waseem Ahmad, Daniel Bouland, Nghia H Nguyen, David T Pride, Siddharth Singh, Parambir S Dulai, William J Sandborn, Brigid S Boland, Digestive Diseases and Sciences
No Benefit of Concomitant 5-Aminosalicylates in Patients with Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data from Cli...
Siddharth Singh, Parambir S Dulai, William J Sandborn, Nature
Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical Trials
Siddharth Singh, William J Sandborn, Nature

List of Advanced Rx Recommended For Moderate to Severe UC ExpandsFebruary 4th, 2025
New AGA Living Guideline Expands Recommended Drugs for Moderate to Severe UCNovember 26th, 2024
New AGA Guidance for Ulcerative Colitis Treatment: 8 Things to KnowNovember 25th, 2024
Join now to see all